Practical vs Recent Clinical Trial Use Of Dalbavancin

JAMA Network Open 2026 Open access

Read full text
Authors: Sarah A. Uhm, Bryan T. Alexander, ELIZABETH R. LYDEN, Nicolás Cortés-Penfield, Harlan R. Sayles, Sara F Azimi, Mackenzie R. Keintz, Molly M. Miller, Mark E. Rupp, Jasmine R. Marcelin
DOI: 10.1001/jamanetworkopen.2026.16508
Cited by: 1
References: 5

Abstract

This quality improvement study compares demographic characteristics and clinical outcomes among patients treated with dalbavancin for bacteremia in clinical practice vs a randomized clinical trial.

Fields of Study & Subjects

Bacterial Identification and Susceptibility Testing Antibiotics Pharmacokinetics and Efficacy Antibiotic Use and Resistance

Publication details

Journal / source
JAMA Network Open
Publisher
American Medical Association (AMA)
Volume
9
Issue
6
Pages
e2616508–e2616508
Publication date
3 June 2026
Language
EN